These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9617748)

  • 1. Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice.
    Decker MW; Bannon AW; Buckley MJ; Kim DJ; Holladay MW; Ryther KB; Lin NH; Wasicak JT; Williams M; Arneric SP
    Eur J Pharmacol; 1998 Apr; 346(1):23-33. PubMed ID: 9617748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization.
    Bannon AW; Decker MW; Curzon P; Buckley MJ; Kim DJ; Radek RJ; Lynch JK; Wasicak JT; Lin NH; Arnold WH; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):787-94. PubMed ID: 9580627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats.
    Boyce S; Webb JK; Shepheard SL; Russell MGN; Hill RG; Rupniak NMJ
    Pain; 2000 Apr; 85(3):443-450. PubMed ID: 10781917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine and ABT-594 (a nicotinic acetylcholine agonist) exert centrally mediated antinociception in the rat cyclophosphamide cystitis model of visceral pain.
    Joshi SK; Mikusa JP; Weaver B; Honore P
    J Pain; 2008 Feb; 9(2):146-56. PubMed ID: 18088559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the nucleus raphe magnus in antinociception produced by ABT-594: immediate early gene responses possibly linked to neuronal nicotinic acetylcholine receptors on serotonergic neurons.
    Bitner RS; Nikkel AL; Curzon P; Arneric SP; Bannon AW; Decker MW
    J Neurosci; 1998 Jul; 18(14):5426-32. PubMed ID: 9651224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of neuronal nicotinic acetylcholine receptors in antinociception: effects of ABT-594.
    Decker MW; Curzon P; Holladay MW; Nikkel AL; Bitner RS; Bannon AW; Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Williams M; Arneric SP
    J Physiol Paris; 1998; 92(3-4):221-4. PubMed ID: 9789812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors.
    Bannon AW; Decker MW; Holladay MW; Curzon P; Donnelly-Roberts D; Puttfarcken PS; Bitner RS; Diaz A; Dickenson AH; Porsolt RD; Williams M; Arneric SP
    Science; 1998 Jan; 279(5347):77-81. PubMed ID: 9417028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive effect of tebanicline for various noxious stimuli-induced behaviours in mice.
    Hayashi T; Katsuyama S; Orito T; Suzuki T; Sakurada S
    Neurosci Lett; 2017 Jan; 638():46-50. PubMed ID: 27939354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective potentiation of gabapentin-mediated antinociception in the rat formalin test by the nicotinic acetylcholine receptor agonist ABT-594.
    Munro G; Dyhr H; Grunnet M
    Neuropharmacology; 2010 Sep; 59(3):208-17. PubMed ID: 20562022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.
    Holladay MW; Wasicak JT; Lin NH; He Y; Ryther KB; Bannon AW; Buckley MJ; Kim DJ; Decker MW; Anderson DJ; Campbell JE; Kuntzweiler TA; Donnelly-Roberts DL; Piattoni-Kaplan M; Briggs CA; Williams M; Arneric SP
    J Med Chem; 1998 Feb; 41(4):407-12. PubMed ID: 9484491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABT-594 (a nicotinic acetylcholine agonist): anti-allodynia in a rat chemotherapy-induced pain model.
    Lynch JJ; Wade CL; Mikusa JP; Decker MW; Honore P
    Eur J Pharmacol; 2005 Feb; 509(1):43-8. PubMed ID: 15713428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of nicotinic acetylcholine and opioid systems of the ventral orbital cortex in modulation of formalin-induced orofacial pain in rats.
    Yousofizadeh S; Tamaddonfard E; Farshid AA
    Eur J Pharmacol; 2015 Jul; 758():147-52. PubMed ID: 25864612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (+/-)-epibatidine in rats.
    Curzon P; Nikkel AL; Bannon AW; Arneric SP; Decker MW
    J Pharmacol Exp Ther; 1998 Dec; 287(3):847-53. PubMed ID: 9864263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effects of the novel spirocyclopiperazinium salt compound LXM-10 in mice.
    Yue CQ; Ye J; Li CL; Li RT; Sun Q
    Pharmacol Biochem Behav; 2007 Apr; 86(4):643-50. PubMed ID: 17379285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping brain activity following administration of a nicotinic acetylcholine receptor agonist, ABT-594, using functional magnetic resonance imaging in awake rats.
    Skoubis PD; Hradil V; Chin CL; Luo Y; Fox GB; McGaraughty S
    Neuroscience; 2006; 137(2):583-91. PubMed ID: 16289887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain.
    Kesingland AC; Gentry CT; Panesar MS; Bowes MA; Vernier JM; Cube R; Walker K; Urban L
    Pain; 2000 May; 86(1-2):113-8. PubMed ID: 10779668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception.
    Khan IM; Stanislaus S; Zhang L; Taylor P; Yaksh TL
    J Pharmacol Exp Ther; 2001 Apr; 297(1):230-9. PubMed ID: 11259549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
    Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
    Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine-induced anxiolytic-like effect in morphine-sensitized mice: involvement of ventral hippocampal nicotinic acetylcholine receptors.
    Rezayof A; Assadpour S; Alijanpour S
    Pharmacol Biochem Behav; 2013 Jan; 103(3):460-6. PubMed ID: 23067878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.